Literature DB >> 19646806

Adiponectin suppresses tumorigenesis in Apc(Min)(/+) mice.

Kensuke Otani1, Joji Kitayama, Koji Yasuda, Yasunori Nio, Masato Iwabu, Shinichi Okudaira, Junken Aoki, Toshimasa Yamauchi, Takashi Kadowaki, Hirokazu Nagawa.   

Abstract

Recent reports have shown that adiponectin has a suppressive effect on various types of malignancy. In order to clarify the role of adiponectin in colorectal carcinogenesis, we examined the effect of exogenous administration of adiponectin on intestinal polyp formation in C57BL/6J-Apc(Min)(/+) mice, which possess a point mutation in the Apc gene. And we found that adiponectin treatment significantly decreased the number of adenomatous polyps, especially polyps larger than 2mm in diameter, in the small intestine. Two major receptors for adiponectin, AdipoR1 and AdipoR2, were expressed in adenomatous polyps, and their expression levels were not altered by adiponectin injection. In conclusion, adiponectin suppresses the growth of intestinal adenomas in the Apc(Min)(/+) mice. Increasing the adiponectin level may be a new strategy for the prevention of colorectal cancer at an early step of carcinogenesis. 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19646806     DOI: 10.1016/j.canlet.2009.06.037

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  19 in total

1.  Pre-diagnostic levels of adiponectin and soluble vascular cell adhesion molecule-1 are associated with colorectal cancer risk.

Authors:  Mathilde Touvier; Léopold Fezeu; Namanjeet Ahluwalia; Chantal Julia; Nathalie Charnaux; Angela Sutton; Caroline Méjean; Paule Latino-Martel; Serge Hercberg; Pilar Galan; Sébastien Czernichow
Journal:  World J Gastroenterol       Date:  2012-06-14       Impact factor: 5.742

Review 2.  The balance between leptin and adiponectin in the control of carcinogenesis - focus on mammary tumorigenesis.

Authors:  Michael E Grossmann; Margot P Cleary
Journal:  Biochimie       Date:  2012-06-20       Impact factor: 4.079

3.  Dietary selenium protects adiponectin knockout mice against chronic inflammation induced colon cancer.

Authors:  Arpit Saxena; Raja Fayad; Kamaljeet Kaur; Samantha Truman; Julian Greer; James A Carson; Anindya Chanda
Journal:  Cancer Biol Ther       Date:  2017-01-03       Impact factor: 4.742

4.  Adiponectin receptor 2 is negatively associated with lymph node metastasis of colorectal cancer.

Authors:  Masaya Hiyoshi; Nelson H Tsuno; Kensuke Otani; Kazushige Kawai; Takeshi Nishikawa; Yasutaka Shuno; Kazuhito Sasaki; Kumiko Hongo; Manabu Kaneko; Eiji Sunami; Koki Takahashi; Hirokazu Nagawa; Joji Kitayama
Journal:  Oncol Lett       Date:  2012-02-07       Impact factor: 2.967

5.  Adiponectin receptor expression in human malignant tissues.

Authors:  Sharon H Chou; Sofia Tseleni-Balafouta; Hyun-Seuk Moon; John P Chamberland; Xiaowen Liu; Nikolaos Kavantzas; Christos S Mantzoros
Journal:  Horm Cancer       Date:  2010-06       Impact factor: 3.869

6.  AdipoRon Attenuates Wnt Signaling by Reducing Cholesterol-Dependent Plasma Membrane Rigidity.

Authors:  Michael L Salinas; Natividad R Fuentes; Rachel Choate; Rachel C Wright; David N McMurray; Robert S Chapkin
Journal:  Biophys J       Date:  2019-09-16       Impact factor: 4.033

7.  Adiponectin is down-regulated in bone marrow interstitial fluid in hematological malignancy.

Authors:  Fan-Yu Lin; Hung-Chang Wu; Kuo-Chen Cheng; Chao-Ling Tung; Chi-Pei Chang; Yin-Hsun Feng
Journal:  Int J Hematol       Date:  2015-06-27       Impact factor: 2.490

8.  AdipoRon: a possible drug for colorectal cancer prevention?

Authors:  Sara Malih; Rezvan Najafi
Journal:  Tumour Biol       Date:  2015-08-18

Review 9.  Molecular pathways: adiponectin and leptin signaling in cancer.

Authors:  Michael N Vansaun
Journal:  Clin Cancer Res       Date:  2013-01-25       Impact factor: 12.531

Review 10.  Adiponectin and colorectal cancer.

Authors:  Kensuke Otani; Soichiro Ishihara; Hironori Yamaguchi; Koji Murono; Koji Yasuda; Takeshi Nishikawa; Toshiaki Tanaka; Tomomichi Kiyomatsu; Keisuke Hata; Kazushige Kawai; Hiroaki Nozawa; Toshiaki Watanabe
Journal:  Surg Today       Date:  2016-04-09       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.